Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial to Evaluate the Safety and Efficacy of DNN.31.19.026 for the Treatment of Ocular Hypertension or Primary Open-Angle Glaucoma

NCT07617532 is registered in ClinicalTrials.gov with Ache Laboratorios Farmaceuticos S.A. as lead sponsor.

NCT NCT07617532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07617532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial to Evaluate the Safety and Efficacy of DNN.31.19.026 for the Treatment of Ocular Hypertension or Primary Open-Angle Glaucoma
Lead sponsor
Ache Laboratorios Farmaceuticos S.A.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
March 31, 2028
Enrollment
336 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, primary open angle glaucoma